InMed Pharmaceuticals Files Provisional Patent Application for Ophthalmic Drug Delivery
InMed Pharmaceuticals | June 01, 2017
Glaucoma is a group of eye diseases which result in damage to the optic nerve and vision loss. Worldwide, it is the second-leading cause of blindness, and the current global market for drug therapies to treat glaucoma exceeds US$5 billion.